These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 5505574)

  • 1. Non-specificity of the "gray" spot (indole derivative) in the urine of schizophrenics.
    Keup W; Seto TA; Gonda O
    Dis Nerv Syst; 1970 Jul; 31(7):476-8. PubMed ID: 5505574
    [No Abstract]   [Full Text] [Related]  

  • 2. Determination of bufotenin in the urine of schizophrenics.
    Fischer E; Spatz H
    Int J Neuropsychiatry; 1967 Jun; 3(3):226-8. PubMed ID: 6034731
    [No Abstract]   [Full Text] [Related]  

  • 3. Studies of drug-free schizophrenics and controls.
    Narasimhachari N; Avalos J; Fujimori M; Himwich HE
    Biol Psychiatry; 1973 Dec; 5(3):311-8. PubMed ID: 4513564
    [No Abstract]   [Full Text] [Related]  

  • 4. Psychotomimetic indole compound in the urine of schizophrenics and mentally defective patients.
    Tanimukai H; Ginther R; Spaide J; Himwich HE
    Nature; 1967 Nov; 216(5114):490-1. PubMed ID: 6057255
    [No Abstract]   [Full Text] [Related]  

  • 5. An evaluation of the efficacy of oxypertine in acute and choronic schizophrenic patients.
    Muniz AF; Terra SO; Bueno JR; Vianna Filho U
    J Bras Psiquiatr; 1968; 17(1):83-95. PubMed ID: 5760628
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical evaluation of mazindol in chronic schizophrenics.
    Krumholz WV; White L
    Curr Ther Res Clin Exp; 1970 Sep; 12(9):609-10. PubMed ID: 4989693
    [No Abstract]   [Full Text] [Related]  

  • 7. Indolic compounds in the urine of schizophrenics.
    LEYTON GB
    Br Med J; 1958 Nov; 2(5105):1136-9. PubMed ID: 13584877
    [No Abstract]   [Full Text] [Related]  

  • 8. The appearance of a skatole derivative in the urine of schizophrenics.
    NAKAO A; BALL M
    J Nerv Ment Dis; 1960 May; 130():417-9. PubMed ID: 14425913
    [No Abstract]   [Full Text] [Related]  

  • 9. Studies in schizophrenia-VI. Paper chromatography of urinary indoles and the "glyoxylic acid" reaction.
    FLEISCHHACKER HH; LANCASTER JB
    J Ment Sci; 1959 Jul; 105():777-82. PubMed ID: 13823418
    [No Abstract]   [Full Text] [Related]  

  • 10. A pilot study of GP-45795 in chronic schizophrenics.
    Sugerman AA
    Curr Ther Res Clin Exp; 1971 Aug; 13(8):549-52. PubMed ID: 4999205
    [No Abstract]   [Full Text] [Related]  

  • 11. [Differential effects of neuroleptic drugs in chronic schizophrenics. A configuration analytical evaluation].
    Eckmann F; Gebert A; Lienert GA
    Arzneimittelforschung; 1974 Aug; 24(8):1135-8. PubMed ID: 4479475
    [No Abstract]   [Full Text] [Related]  

  • 12. Psychopharmacologic characteristics of an indole compound--molindone.
    Claghorn JL
    Curr Ther Res Clin Exp; 1969 Aug; 11(8):524-7. PubMed ID: 4979704
    [No Abstract]   [Full Text] [Related]  

  • 13. Evaluation of the antipsychotic activity of an indole analogue, AL-1612.
    Elizur A; Gershon S
    Curr Ther Res Clin Exp; 1971 Sep; 13(9):584-90. PubMed ID: 5000461
    [No Abstract]   [Full Text] [Related]  

  • 14. Significance of hydroxyskatole and mauve factor excretion in schizophrenia.
    Sohler A; Renz RH; Smith S; Kaufman J
    Int J Neuropsychiatry; 1967 Aug; 3(4):327-31. PubMed ID: 6064120
    [No Abstract]   [Full Text] [Related]  

  • 15. [Occurrence of the mauve factor in schizophrenia].
    Gebel L
    Psychiatr Pol; 1973; 7(2):153-9. PubMed ID: 4710987
    [No Abstract]   [Full Text] [Related]  

  • 16. Psychotogenic N,N-Dimethylated indole amines and behavior in schizophrenic patients.
    Tanimukai H; Ginther R; Spaide J; Bueno JR; Himwich HE
    Recent Adv Biol Psychiatry; 1968; 10():6-15. PubMed ID: 4873523
    [No Abstract]   [Full Text] [Related]  

  • 17. Urinary excretion of indoles in schizophrenia.
    CURZON G
    Confin Neurol; 1958; 18(2-4):211-6. PubMed ID: 13597497
    [No Abstract]   [Full Text] [Related]  

  • 18. Urinary excretion of catecholamines and their metabolites in chronic schizophrenics treated with oxypertine and chlorpromazine.
    Kiriike N; Uete T; Motomura K; Enomoto M; Murata K
    Biol Psychiatry; 1984 Mar; 19(3):417-22. PubMed ID: 6144330
    [No Abstract]   [Full Text] [Related]  

  • 19. [Neuroleptics in the prevention of acute psychotic phases of schizophrenia].
    Huttunen MO
    Duodecim; 1977; 93(7):407-9. PubMed ID: 852439
    [No Abstract]   [Full Text] [Related]  

  • 20. Piperacetazine in chronic schizophrenia.
    Climo HJ; Billett B
    JFMA; 1972 Mar; 59(3):33-6. PubMed ID: 5030683
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.